Clinical trials
Endometrial Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
161 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 5 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 8 |
| 2020 | 13 |
| 2021 | 11 |
| 2022 | 22 |
| 2023 | 16 |
| 2024 | 27 |
| 2025 | 30 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 66 |
| Unknown status | 40 |
| Not yet recruiting | 19 |
| Active, not recruiting | 17 |
| Completed | 11 |
| Terminated | 6 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 17 |
| Lei Li | 8 |
| AstraZeneca | 7 |
| Fudan University | 7 |
| Merck Sharp & Dohme LLC | 6 |
| Peking Union Medical College Hospital | 5 |
| Sun Yat-sen University | 5 |
| Tongji Hospital | 5 |
| Women's Hospital School Of Medicine Zhejiang University | 4 |
| Xiaojun Chen | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 161 |
| Uterine Cervical Neoplasms | 42 |
| Ovarian Neoplasms | 41 |
| Breast Neoplasms | 22 |
| Carcinoma, Non-Small-Cell Lung | 17 |
| Stomach Neoplasms | 15 |
| Colorectal Neoplasms | 12 |
| Neoplasms | 12 |
| Endometrial Hyperplasia | 11 |
| Neoplasm Metastasis | 11 |
Trials
Showing 26 to 50 of 161. Each trial links to its page on Pharma Observatory.
61 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.